SEOVF (Sernova Biotherapeutics) Moat Score: 3/10 (As of Jul. 02, 2026)


SEOVF Sernova Biotherapeutics Inc SEOVF
30 GF Score
Price $0.09
! 2 Warning Signs
View Full Analysis

What is Sernova Biotherapeutics Moat Score?

Sernova Biotherapeutics SEOVF -9.27% 30 Moat Score is 3 as of Jul. 02, 2026. GuruFocus rates SEOVF with a GF Score™ of 30/100. The stock has 2 warning signs investors should review. Among 1,400 Biotechnology companies, Sernova Biotherapeutics ranks better than 75.5% on this metric.

Sernova Biotherapeutics has the Moat Score of 3, which implies that the company might have No Moat - Very weak/transient advantages.

Sernova Biotherapeutics has No Moat: Sernova Biotherapeutics Inc has a very weak competitive position with limited market share and customer loyalty. It lacks significant intellectual property, regulatory barriers, and pricing power, resulting in a transient competitive advantage.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Sernova Biotherapeutics might have No Moat - Very weak/transient advantages.

Sernova Biotherapeutics  (OTCPK:SEOVF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Sernova Biotherapeutics Moat Score Related Terms

SEOVF vs VRTX, REGN, ALNY: Moat Score Comparison

For the Biotechnology subindustry, Sernova Biotherapeutics's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sernova Biotherapeutics Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sernova Biotherapeutics's Moat Score distribution charts can be found below:

* The bar in red indicates where Sernova Biotherapeutics's Moat Score falls into.


SEOVF
30GF Score
Sernova Biotherapeutics Inc SEOVF
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 3 mean?
Sernova Biotherapeutics (SEOVF) has a Moat Score of 3 as of Jul. 02, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Sernova Biotherapeutics ranks #343 out of 1400 companies in the Biotechnology industry, placing it in the top 24.5%.
Is Sernova Biotherapeutics' Moat Score too high?
Sernova Biotherapeutics' current Moat Score is 3. The Biotechnology industry median Moat Score is 2.00. Sernova Biotherapeutics' value of 3 is 50% above this industry median. Based on the distribution chart, Sernova Biotherapeutics ranks #343 out of 1400 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Sernova Biotherapeutics has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Sernova Biotherapeutics' Moat Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sernova Biotherapeutics ranks #343 out of 1400 companies for Moat Score. This places Sernova Biotherapeutics in the top 25% of its industry — outperforming the majority of peers. The industry median Moat Score is 2.00. Sernova Biotherapeutics' value of 3 is 50% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,400 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sernova Biotherapeutics's current Moat Score of 3 is 50% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sernova Biotherapeutics's current Moat Score is 3. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sernova Biotherapeutics stock overvalued right now?
Sernova Biotherapeutics (SEOVF) has a current Moat Score of 3. The current Moat Score is 3 and 50% above the Biotechnology industry median of 2.00. Sernova Biotherapeutics' overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Sernova Biotherapeutics (SEOVF), the current Moat Score is 3 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sernova Biotherapeutics Business Description

Other Exchanges PSH0:GermanySVA:Canada
Address RPO Central Parkway, PO Box 29592, Mississauga, ON, CAN, L5A 4H2
Sernova Biotherapeutics Inc is a clinical-stage biotechnology company focused on advancing regenerative medicine for the treatment of chronic diseases. The Company's primary asset is its proprietary Cell Pouch, a bio-hybrid organ system designed to enhance the delivery of cell therapy by replicating natural body functions. The Cell Pouch creates a vascularized, organ-like environment that promotes the longevity and functionality of therapeutic cells and ensures containment for retrievability.
30GF Score

Get the complete analysis for SEOVF

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.09
Price